HYGROBUFF ADJUVANT Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

hygrobuff adjuvant

ekko solutions pty ltd - acetate anion present as the acid and sodium salt; alkylaryl polyoxyethylene - glycol phosphate ester - liquid - acetate anion present as the acid and sodium salt acetate active 370.0 g/l; alkylaryl polyoxyethylene - glycol phosphate ester petroleum derivative-oil active 85.0 g/l - adjuvant - agricultural chemical additive | spray activator | spreading agent | wetting agent - tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank

NUFARM LIASE LIQUID HERBICIDE ADJUVANT Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm liase liquid herbicide adjuvant

nufarm australia limited - ammonium sulfate - liquid - ammonium sulfate ammonium active 417.0 g/l - adjuvant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank

Smart Penetrator Spray Adjuvant Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

smart penetrator spray adjuvant

crop smart pty ltd - vegetable oil ester - emulsifiable concentrate - vegetable oil ester oil-plant extract active 700.0 g/l - adjuvant

F.S.A. Sticken Spray Adjuvant Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

f.s.a. sticken spray adjuvant

four seasons agribusiness pty ltd - methyl & ethyl esters of free fatty acids from canola oi - emulsifiable concentrate - methyl & ethyl esters of free fatty acids from canola oi acid-fatty active 704.0 g/l - adjuvant

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals Den europeiske union - ungarsk - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals

glaxosmithkline biologicals s.a. - inaktivált, antigént tartalmazó influenza vírus: a / vietnam / 1194/2004 (h5n1), mint a használt törzs (nibrg-14) - influenza, human; immunization; disease outbreaks - a vakcinák - aktív immunizálás az influenza a vírus h5n1 altípusa ellen. ez a jelzés alapján immunogenitási adatok az egészséges személyek kortól 18 éves kezdődően alkalmazását követően, két adag oltóanyag készült a/vietnam/1194/2004 nibrg-14 (h5n1) (lásd 5. a prepandémiás influenza (h5n1) vakcina (split virion, inaktivált, adjuvánshoz kötött) glaxosmithkline biologicals 3. 75 µg kell alkalmazni hivatalos ajánlásoknak megfelelően.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Den europeiske union - italiensk - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccini - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals Den europeiske union - dansk - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals

glaxosmithkline biologicals s.a. - splittet influenzavirus, inaktiveret, indeholdende antigen: a / vietnam / 1194/2004 (h5n1) som brugt belastning (nibrg-14) - influenza, human; immunization; disease outbreaks - vacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. denne angivelse er baseret på immunogenicitet data fra raske forsøgspersoner i alderen fra 18 år og op efter administration af to doser vaccine, der er fremstillet af en/vietnam/1194/2004 nibrg-14 (h5n1) (se afsnit 5. prepandemic influenza vaccine (h5n1) (split virion, inaktiveret, adjuvanted) glaxosmithkline biologicals 3. 75 µg bør anvendes i overensstemmelse med officielle retningslinjer.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Den europeiske union - gresk - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - Εμβόλια - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Den europeiske union - dansk - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - splittet influenzavirus, inaktiveret, indeholdende antigen: a / vietnam / 1194/2004 (h5n1) som brugt belastning (nibrg-14) - influenza, human; immunization; disease outbreaks - vacciner - prophylax af influenza i en officielt erklæret pandemisk situation. pandemic influenza vaccine bør anvendes i overensstemmelse med officielle retningslinjer.

isoCLEAR HPO nC23 Horticultural Paraffinic oil Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

isoclear hpo nc23 horticultural paraffinic oil

adjuvant technical & marketing services pty ltd - unsulphonatable residue; nc23 paraffinic oil - emulsifiable concentrate - unsulphonatable residue ungrouped active 0.0 u; nc23 paraffinic oil active 812.0 g/l - insecticide